DIA 49th Annual Meeting

Ono Pharmaceutical

AMRI, Ono Pharma broaden Smartsourcing collaboration

Monday, April 29, 2013 11:21 AM

AMRI, a global contract research and manufacturing organization, has entered into a new five-year service agreement with Ono Pharmaceutical, a pharmaceutical company based in Osaka, Japan

More... »


Galapagos subsidiary BioFocus collaborates with Ono on CNS drug discovery

Tuesday, September 4, 2012 12:46 PM

Galapagos’ service division BioFocus and Ono Pharmaceutical have signed a new collaboration agreement focused on discovering novel drugs for CNS disorders. BioFocus will use its drug discovery platform to deliver leads and clinical candidates.

More... »

CRF Health: Supporting Monitors & Investigators in Clinical Trials, April 25, May 16

Drug reduced number of MS lesions in phase II trial

Wednesday, April 18, 2012 12:37 PM

An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase II clinical trial supported by Ono Pharmaceutical.

More... »

Tioga raises $10 million for irritable bowel syndrome trial

Friday, April 13, 2012 01:26 PM

Tioga Pharmaceuticals of San Diego has closed its $10 million Series B equity financing led by new investor Thomas, McNerney & Partners, which invested $8 million in the round.

More... »

Merck, Ono Pharmaceutical collaborate

Tuesday, October 4, 2011 01:33 PM

Merck Serono has signed two separate agreements with Ono Pharmaceutical, Osaka, Japan to strengthen its multiple sclerosis and cancer franchises.

More... »

Xention, Ono continue collaboration

Tuesday, April 12, 2011 11:21 AM

Xention, a Cambridge, U.K.-based biopharmaceutical company that discovers and develops ion channel-modulating drugs, will extend its collaboration with Ono Pharmaceutical.  The two-year agreement between the companies began in March 2009.  The collaboration has been successful in identifying multiple compounds that selectively modulate the function of target ion channels, and the two have agreed to extend the drug-discovery collaboration for another year.

More... »

CenterWatch Medical Writing: Innovative Solutions
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.